These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 34834272)
1. Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments. Buyukgoz GG; Kossor CG; Davé RN Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834272 [TBL] [Abstract][Full Text] [Related]
2. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
3. Exploring tablet design options for tailoring drug release and dose via fused deposition modeling (FDM) 3D printing. Gorkem Buyukgoz G; Soffer D; Defendre J; Pizzano GM; Davé RN Int J Pharm; 2020 Dec; 591():119987. PubMed ID: 33069894 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676 [TBL] [Abstract][Full Text] [Related]
5. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary. Serajuddin ATM ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904 [TBL] [Abstract][Full Text] [Related]
6. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
7. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion. Bhatt U; Malakar TK; Murty US; Banerjee S Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008 [TBL] [Abstract][Full Text] [Related]
8. Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction. Patel NG; Serajuddin ATM Int J Pharm; 2023 Feb; 632():122542. PubMed ID: 36566823 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet. Nyavanandi D; Mandati P; Narala S; Alzahrani A; Kolimi P; Pradhan A; Bandari S; Repka MA Int J Pharm; 2022 Nov; 628():122283. PubMed ID: 36244563 [TBL] [Abstract][Full Text] [Related]
10. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
11. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
12. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion. Oh HS; Park JB Int J Pharm; 2024 Aug; 661():124407. PubMed ID: 38955239 [TBL] [Abstract][Full Text] [Related]
13. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing. Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing. Hoffmann L; Breitkreutz J; Quodbach J Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059 [TBL] [Abstract][Full Text] [Related]
15. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
16. Dose Titration of Solid Dosage Forms via FDM 3D-Printed Mini-Tablets. Gorkem Buyukgoz G; Kossor CG; Ji S; Guvendiren M; Davé RN Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365124 [TBL] [Abstract][Full Text] [Related]
17. Orodispersible Polymer Films with the Poorly Water-Soluble Drug, Olanzapine: Hot-Melt Pneumatic Extrusion for Single-Process 3D Printing. Cho HW; Baek SH; Lee BJ; Jin HE Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32707862 [TBL] [Abstract][Full Text] [Related]
18. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing. Zhang P; Xu P; Chung S; Bandari S; Repka MA Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460 [TBL] [Abstract][Full Text] [Related]
19. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance. Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957 [TBL] [Abstract][Full Text] [Related]
20. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]